Home > Journals > Minerva Respiratory Medicine > Past Issues > Minerva Pneumologica 2010 March;49(1) > Minerva Pneumologica 2010 March;49(1):33-43

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Share

 

REVIEWS   

Minerva Pneumologica 2010 March;49(1):33-43

Copyright © 2010 EDIZIONI MINERVA MEDICA

language: English

Controversies in the surgical treatment of non-small cell lung cancer

Tomaszek S. C., Wigle D. A.

Division of General Thoracic Surgery, Mayo Clinic, Rochester, MN USA


PDF


Lung cancer continues to be one of the most frequent cancer-related causes of death worldwide. Despite the general acknowledgment that surgical resection is the most effective treatment in non-small cell lung cancer, there remains significant areas of controversy in the application of surgical resection. Appropriate patient selection must be based on the assessment of benefits and risks involved for the patient. This decision, however, is multifactorial and approached differently by surgeons worldwide based on a combination of training, clinical practice experience and available research data. Efficacy of competing non-invasive and invasive mediastinal staging modalities, the extent of mediastinal staging and surgical resection, as well as whether there is a role for surgery in locally advanced or metastatic lung cancer are further controversial topics addressed in this review.

top of page